Pharmacogenomics News and Research

RSS
The terms pharmacogenomics and pharmacogenetics are often used interchangeably to describe a field of research focused on how genes affect individual responses to medicines. Whether a medicine works well for you—or whether it causes serious side effects—depends, to a certain extent, on your genes.
Genetics and race influence patients' response to anticancer drug treatments

Genetics and race influence patients' response to anticancer drug treatments

SKA2 gene may play a role in development of PTSD

SKA2 gene may play a role in development of PTSD

Stanford University launches new professional education course

Stanford University launches new professional education course

Moffitt researchers analyze participation rate of patients in pharmacogenomic trials

Moffitt researchers analyze participation rate of patients in pharmacogenomic trials

Drug addiction expert uncovers molecular mechanisms that contribute to addiction resistance

Drug addiction expert uncovers molecular mechanisms that contribute to addiction resistance

Vanderbilt receives $12.8 million federal grant to develop better ways to predict effects of drugs in patients

Vanderbilt receives $12.8 million federal grant to develop better ways to predict effects of drugs in patients

Penn study suggests future precision medicine approach to treating diabetes, other metabolic disorders

Penn study suggests future precision medicine approach to treating diabetes, other metabolic disorders

DTC genetic testing has negative consequences in children

DTC genetic testing has negative consequences in children

7th Annual Personalized & Precision Medicine Conference to be held in Baltimore from Oct. 5 to 6, 2015

7th Annual Personalized & Precision Medicine Conference to be held in Baltimore from Oct. 5 to 6, 2015

Future Cardiology’s special issue focuses on recent advances, challenges in cardiology

Future Cardiology’s special issue focuses on recent advances, challenges in cardiology

Substantial pharmacogenetic information available on cardiovascular drugs

Substantial pharmacogenetic information available on cardiovascular drugs

Study quantifies different mutational profiles of tumour cell clusters in patients with bowel cancer

Study quantifies different mutational profiles of tumour cell clusters in patients with bowel cancer

Agena Bioscience releases LungFUSION Panel to identify gene fusions in NSCLC tumors

Agena Bioscience releases LungFUSION Panel to identify gene fusions in NSCLC tumors

UF pharmacy dean to be honored with 2015 SURA Distinguished Scientist Award

UF pharmacy dean to be honored with 2015 SURA Distinguished Scientist Award

GeneSight test better predicts antidepressant outcomes for patients with depression

GeneSight test better predicts antidepressant outcomes for patients with depression

Researchers identify first genetic variation linked to increased risk of peripheral neuropathy

Researchers identify first genetic variation linked to increased risk of peripheral neuropathy

Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

Personalized prevention, treatments of cancer now accessible through Stanford University's new genetics course

Personalized prevention, treatments of cancer now accessible through Stanford University's new genetics course

Two genetic mutations can interact to reduce risk for heart attack

Two genetic mutations can interact to reduce risk for heart attack

New initiative aims at reducing adverse effects of medications in individuals with mental illnesses

New initiative aims at reducing adverse effects of medications in individuals with mental illnesses